TITLE

The Relationship Between the Content of Aggressive and Protective Components in Gastric Juice and Endoscopic Findings After Naproxen Sodium and Acetaminophen Administration

AUTHOR(S)
Marcinkiewicz, Marek; Peura, David A.; Sarosiek, Jerzy
PUB. DATE
February 1996
SOURCE
American Journal of Gastroenterology;Feb1996, Vol. 91 Issue 2, p360
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objectives: To evaluate the diagnostic value of residual gastric juice, we assessed various secretory components before and after placebo, acetaminophen, or naproxen sodium administration. Methods: In a double-blind, randomized, cross-over study in 30 asymptomatic volunteers, mucin, hydrophobicity, protein, pepsin, and pH were measured in residual gastric juice before and after placebo, naproxen sodium (660 mg/d), or acetaminophen (4000 mg/d) administration. Mucus layer thickness in biopsy specimens was assessed, and mucosal damage was endoscopically evaluated. Results: All parameters were unchanged after 7 days of placebo. Naproxen caused a 46% (p = 0.008) increase in the rate of luminal mucin release, an 18% increase (p = 0.510) in protein release, and a 61% decrease (p = 0.001) in hydrophobicity. Antral and duodenal mucus gel thickness were compromised, and hemorrhagic and erosive endoscopic changes were noted. Acetaminophen resulted only in a significant decline of pepsin. In subjects without endoscopic damage after naproxen, a nonsignificant decrease in hydrophobicity was noted. However, in subjects with endoscopic changes, a 55% decrease (p = 0.002) in hydrophobicity and a 42% increase (p = 0.024) in the rate of luminal mucin release were demonstrated. The initial mucin of subjects who developed endoscopic mucosal changes after naproxen was 53% higher than in subjects without damage. Subjects with endoscopic changes also exhibited a 48% lower initial hydrophobicity and a 43 % lower pepsin than subjects without endoscopic changes. Conclusions: Gastric mucosal damage after naproxen sodium results in profound changes within the gastric mucosal barrier, and analysis of residual gastric juice components adequately reflects these changes. In contrast, acetaminophen results in only minimal gastric juice changes. Analysis of residual gastric juice may be useful in monitoring the extent of mucosal damage and identifying...
ACCESSION #
16440282

 

Related Articles

  • TRANQUILIZERS AND GASTRIC SECRETION. Lichstein, Jacob // American Journal of Gastroenterology;Feb1960, Vol. 33 Issue 2, p178 

    Presents findings of study on the effect of tranquilizers thiopropazate dihychloride and prochloperazine-isopropamide on gastric secretion. Effect of thiopropazate on gastric secretion; Materials and methods used; Comparison of the effect of prochloperazine-isopropamide, prochloperazine and...

  • Prostaglandin E2 Content in Residual Gastric Juice Reflects Endoscopic Damage to the Gastric Mucosa After Naproxen Sodium Administration. Sarosiek, Jerzy; Marcinkiewicz, Marek; Parolisi, Stella; Peura, David A. // American Journal of Gastroenterology;May1996, Vol. 91 Issue 5, p873 

    Objectives: The diagnostic potential of residual gastric juice for development of naproxen sodium-induced mucosal damage has not been explored. We studied prostaglandin E2 (PGE2) content in residual gastric juice before and after naproxen sodium administration and assessed relationships with...

  • Gastric Pepsin Secretion After Prolonged Use of Cimetidine. Achord, James L. // American Journal of Gastroenterology;Dec1980, Vol. 74 Issue 6, p490 

    Eleven patients with proven duodenal ulcer disease but no crater endoscopically were placed on a double-blind, 12-month study of cimetidine vs. placebo b.i.d. There was no evidence of either pepsin or acid rebound hypersecretion at the end of the 12-month study and no obvious differences in this...

  • Association between Increased Gastric Juice Acidity and Sliding Hiatal Hernia Development in Humans. Kishikawa, Hiroshi; Kimura, Kayoko; Ito, Asako; Arahata, Kyoko; Takarabe, Sakiko; Kaida, Shogo; Kanai, Takanori; Miura, Soichiro; Nishida, Jiro // PLoS ONE;1/20/2017, Vol. 12 Issue 1, p1 

    Objectives: Several clinical factors; overweight, male gender and increasing age, have been implicated as the etiology of hiatal hernia. Esophageal shortening due to acid perfusion in the lower esophagus has been suggested as the etiological mechanism. However, little is known about the...

  • Drug Combo Better for Migraine Treatment.  // Clinical Cardiology Alert;May2007, Vol. 26 Issue 5, p2 

    The article reports on the results of studies regarding the drug combination in the treatment of acute migraine. They found that the combination of sumatriptan and naproxen is superior to placebo in sustained pain-free response. It was stated that the incidence of adverse effects is similar...

  • Editorial. Czap, Al // Alternative Medicine Review;Aug2003, Vol. 8 Issue 3, p222 

    Discusses several studies on the digestive ability and absorption capability of the aged. "Ginkgo for Memory Enhancement," by Solomon; "Effects of Rofecoxib or Naproxen vs. Placebo on Alzheimer Disease Progression," by Aisen; Peak plasma drug concentration in the elderly.

  • Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis. Kivitz, Alan; Eisen, Glenn; Zhao, William W.; Bevirt, Terry; Recker, David P. // Journal of Family Practice;Jun2002, Vol. 51 Issue 6, p530 

    -* OBJECTIVE We compared the efficacy and upper gastrointestinal safety of the cyclooxygenase-2-specific inhibitor valdecoxib with naproxen and placebo in treating moderate to severe osteoarthritis of the knee. * STUDY DESIGN This multicenter, randomized, double-blind, placebo-controlled study...

  • Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial. Miner Jr, Philip; Orr, William; Filippone, Joseph; Jokubaitis, Leonard; Sloan, Sheldon // American Journal of Gastroenterology;Jun2002, Vol. 97 Issue 6, p1332 

    OBJECTIVES:Clinical results to date suggest that antisecretory therapy may be less effective in providing symptom relief for patients with nonerosive gastroesophageal reflux disease (GERD) than for patients with erosive disease. This study was carried out to assess the efficacy and rapidity of...

  • Matching pill to pain. Young, Stephanie // Glamour;Nov95, Vol. 93 Issue 11, p45 

    Compares four basic types of pain-relief medications. Aspirin; Acetaminophen; Ibuprofen; Naproxen sodium; Ailments that can and cannot be treated by the drugs; General use guidelines.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics